This list is an analysis based on recent market events. It's not an investment recommendation.
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
FAQs
What is Kardigan stock price today?▼
The current price of KARD is $14.13 USD — it has decreased by -1.26% in the past 24 hours. Watch Kardigan stock price performance more closely on the chart.
What is Kardigan stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Kardigan stocks are traded under the ticker KARD.
What is Kardigan market cap?▼
Today Kardigan has the market capitalization of 1.32B
When is the next Kardigan earnings date?▼
Kardigan is going to release the next earnings report on December 2, 2026.
What were Kardigan earnings last quarter?▼
KARD earnings for the last quarter are -4.61 USD per share, whereas the estimation was -0.68 USD resulting in a -582.61% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Kardigan have?▼
As of November 2, 2026, the company has 241 employees.
In which sector is Kardigan located?▼
Kardigan operates in the Health & Wellness sector.
When did Kardigan complete a stock split?▼
Kardigan has not had any recent stock splits.
Where is Kardigan headquartered?▼
Kardigan is headquartered in SOUTH SAN FRANCISCO, United States.